Technical Analysis for PGEN - Precigen, Inc.

Grade Last Price % Change Price Change
grade B 7.49 0.13% 0.01
PGEN closed up 0.13 percent on Friday, November 27, 2020, on 1.23 times normal volume. The bulls were able to push the stock to a new 52-week high. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up
Historical PGEN trend table...

Date Alert Name Type % Chg
New 52 Week Closing High Bullish 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Calm After Storm Range Contraction 0.00%
Doji - Bearish? Reversal 0.00%
New 52 Week High Strength 0.00%
Stochastic Reached Overbought Strength 0.00%
Upper Bollinger Band Walk Strength 0.00%
Wide Bands Range Expansion 0.00%
Above Upper BB Strength 0.00%
Overbought Stochastic Strength 0.00%
Older End-of-Day Signals for PGEN ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Precigen, Inc. engages in the engineering and industrialization of biology in the United States. The company, through a suite of proprietary and complementary technologies, designs, builds, and regulates gene programs, which are DNA sequences that consist of key genetic components. It provides reproductive technologies and other genetic processes to cattle breeders and producers; biological insect control solutions; technologies for non-browning apple without the use of artificial additives; genetically engineered swine for medical and genetic research; commercial aquaculture products; and preservation and cloning technologies. The company also offers UltraVector platform that enables design and assembly of gene programs that facilitate control over the quality, function, and performance of living cells; and RheoSwitch inducible gene switch that provides quantitative dose-proportionate regulation of the amount and timing of target protein expression. In addition, it provides AttSite Recombinases, which allows stable, targeted gene integration and expression; LEAP automated platform to identify and purify cells of interest, such as antibody expressing cells and stem cells; ActoBiotics platform for targeted in situ expression of proteins and peptides from engineered microbes; and AdenoVerse technology platform for tissue specificity and target selection. The company serves the health, food, energy, and environment markets. Precigen, Inc. has collaboration and license agreements with ZIOPHARM Oncology, Inc.; Ares Trading S.A.; Oragenics, Inc.; Intrexon T1D Partners, LLC; Intrexon Energy Partners, LLC; Intrexon Energy Partners II, LLC; Genopaver, LLC; Fibrocell Science, Inc.; Persea Bio, LLC; OvaXon, LLC; S & I Ophthalmic, LLC; Harvest start-up entities; and Surterra Wellness. The company was formerly known as Intrexon Corporation and changed its name to Precigen, Inc. in January 2020. Precigen, Inc. was founded in 1998 and is based in Germantown, Maryland.
Energy Biotechnology Food Life Sciences Biology Emerging Technologies Stem Cells Molecular Biology Gene Expression Genetic Engineering Biological Engineering

Is PGEN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Recent News

Date Title
Nov 29 PGEN, MESO & LOOP Class Action Deadlines: Bronstein, Gewirtz & Grossman LLC Reminds Investors of Class Actions and Encourages Investors to Contact the Firm
Nov 28 PGEN 6-DAY DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages Precigen, Inc. (PGEN) Investors with Losses to Contact Its Attorneys, Securities Fraud Deadline Approaching
Nov 28 INVESTOR ALERT: ROSEN, A TOP LAW FIRM, Reminds Precigen, Inc. f/k/a Intrexon Corporation Investors of Important December 4 Deadline in First Filed Securities Class Action Commenced by the Firm; Encourages Investors with Losses in Excess of $100K to Con...
Nov 27 UPCOMING DEADLINE: Pawar Law Group Announces a Securities Class Action Lawsuit Against Precigen, Inc. f/k/a Intrexon-- PGEN, XON
Nov 27 7-DAY DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Precigen, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Nov 27 72 Biggest Movers From Wednesday
Nov 26 DECEMBER 4 DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Precigen, Inc. and Encourages Investors with Losses in Excess of $250,000 to Contact the Firm
Nov 25 HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Precigen, Inc. (PGEN) Investors of December 4th Application Deadline, Encourages Investors with Losses to Contact Its Attorneys
Nov 25 Scott+Scott Attorneys at Law LLP Alerts Investors to December 4 Lead Plaintiff Deadline in Securities Class Actions Against Precigen, Inc. (PGEN)
Nov 25 FINAL DEADLINE: FIRST FILING AND LEADING ROSEN LAW FIRM, Encourages Precigen, Inc. f/k/a Intrexon Corporation Investors with Losses Over $100K Seek Counsel Before Important December 4 Deadline in Securities Class Action - PGEN, XON
See more PGEN news...

Indicators

Indicator Value
52 Week High 7.97
52 Week Low 1.26
Average Volume 1,124,382
200-Day Moving Average 4.15
50-Day Moving Average 4.87
20-Day Moving Average 5.78
10-Day Moving Average 6.40
Average True Range 0.55
ADX 46.66
+DI 41.61
-DI 7.88
Chandelier Exit (Long, 3 ATRs ) 6.32
Chandelier Exit (Short, 3 ATRs ) 5.60
Upper Bollinger Band 7.49
Lower Bollinger Band 4.08
Percent B (%b) 1.0
BandWidth 58.95
MACD Line 0.59
MACD Signal Line 0.45
MACD Histogram 0.1391
Fundamentals Value
Market Cap 1.39 Billion
Num Shares 185 Million
EPS -2.09
Price-to-Earnings (P/E) Ratio -3.59
Price-to-Sales 9.72
Price-to-Book 19.26
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 8.72
Resistance 3 (R3) 8.74 8.36 8.52
Resistance 2 (R2) 8.36 8.04 8.35 8.45
Resistance 1 (R1) 7.92 7.85 8.14 7.90 8.38
Pivot Point 7.54 7.54 7.65 7.53 7.54
Support 1 (S1) 7.10 7.22 7.32 7.08 6.60
Support 2 (S2) 6.72 7.03 6.71 6.53
Support 3 (S3) 6.28 6.72 6.47
Support 4 (S4) 6.26